Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K J Scanlon

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
Gene Therapy|March 1, 2000
Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cellsT Suzuki, B Anderegg, T Ohkawa, et al.
Biochemical and Biophysical Research Communications|August 14, 2001
Reversal of cisplatin and multidrug resistance by ribozyme-mediated glutathione suppressionJ Nagata, H Kijima, H Hatanaka, et al.
Anticancer Research|June 9, 2001
Modulation of multidrug resistance in a cancer cell line by anti-multidrug resistance-associated protein (MRP) ribozymeH Hatanaka, Y Abe, M Naruke, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
Gene Therapy|March 1, 2000
Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cellsT Suzuki, B Anderegg, T Ohkawa, et al.
Biochemical and Biophysical Research Communications|August 14, 2001
Reversal of cisplatin and multidrug resistance by ribozyme-mediated glutathione suppressionJ Nagata, H Kijima, H Hatanaka, et al.
Anticancer Research|June 9, 2001
Modulation of multidrug resistance in a cancer cell line by anti-multidrug resistance-associated protein (MRP) ribozymeH Hatanaka, Y Abe, M Naruke, et al.
Pageof 9